Ying Men
CCL19/CCL21-triggered signal transduction and migration of dendritic cells requires prostaglandin E2
Scandella E, Men Y, Legler D, Gillessen Sommer S, Prikler L, Ludewig B, Groettrup M. CCL19/CCL21-triggered signal transduction and migration of dendritic cells requires prostaglandin E2. Blood 2004; 103:1595-601.
01.03.2004CCL19/CCL21-triggered signal transduction and migration of dendritic cells requires prostaglandin E2
01.03.2004Blood 2004; 103:1595-601
Scandella Elke, Men Ying, Legler Daniel F, Gillessen Sommer Silke, Prikler Ladislav, Ludewig Burkhard, Groettrup Marcus
Adaptive Immuntherapie des fortgeschrittenen Prostatakarzinoms
Prikler L, Scandella E, Men Y, Engeler D, Diener P, Gillessen Sommer S, Ludewig B, Schmid H. Adaptive Immuntherapie des fortgeschrittenen Prostatakarzinoms - Cancer Testis Antigene (CTA) als mögliche Zielantigene. Aktuel Urol 2004; 35:326-330.
01.01.2004Adaptive Immuntherapie des fortgeschrittenen Prostatakarzinoms
01.01.2004Aktuel Urol 2004; 35:326-330
Prikler Ladislav, Scandella Elke, Men Ying, Engeler Daniel, Diener Pierre-André, Gillessen Sommer Silke, Ludewig Burkhard, Schmid Hans-Peter
Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells
Scandella E, Men Y, Gillessen Sommer S, Förster R, Groettrup M. Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells. Blood 2002; 100:1354-61.
15.08.2002Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells
15.08.2002Blood 2002; 100:1354-61
Scandella Elke, Men Ying, Gillessen Sommer Silke, Förster Reinhold, Groettrup Marcus